Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ovarian Neoplasms

  Free Subscription


Articles published in Eur J Obstet Gynecol Reprod Biol

Retrieve available abstracts of 48 articles:
HTML format



Single Articles


    November 2021
  1. SHIGEYAMA M, Yoshihara M, Kitami K, Mogi K, et al
    Long-term post-recurrence survival outcomes in young women receiving fertility-sparing surgery for epithelial ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:221-225.
    PubMed     Abstract available


    October 2021
  2. FRIEDRICH L, Meyer R, Levin G
    Management of adnexal mass: A comparison of five national guidelines.
    Eur J Obstet Gynecol Reprod Biol. 2021;265:80-89.
    PubMed     Abstract available


  3. KERSHAW V, Hickey I, Wyld L, Jha S, et al
    The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;265:7-17.
    PubMed     Abstract available


  4. JEFFERY HE, Gillespie AM, Macdonald M
    Evaluation of women referred to the two-week wait gynaecology clinic with suspected ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2021;266:145-149.
    PubMed     Abstract available


    August 2021
  5. LIU G, Wang Y, Chen Y, Ren F, et al
    Malignant transformation of abdominal wall endometriosis: A systematic review of the epidemiology, diagnosis, treatment, and outcomes.
    Eur J Obstet Gynecol Reprod Biol. 2021;264:363-367.
    PubMed     Abstract available


    July 2021
  6. SHARMA JB, Kumar R, Singh U, Kumari A, et al
    Pre treatment and post treatment positron emission tomography-computed tomography (PET-CT) to evaluate treatment response in tuberculous Tubo-Ovarian masses.
    Eur J Obstet Gynecol Reprod Biol. 2021;264:128-134.
    PubMed     Abstract available


  7. KANNEGANTI A, Bhadiraju P, Tong PSY
    Extragonadal teratomas in women and adolescent girls: A systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2021;262:134-141.
    PubMed     Abstract available


    June 2021
  8. NEF J, Huber DE
    Ovarian Sertoli-Leydig cell tumours: A systematic review of relapsed cases.
    Eur J Obstet Gynecol Reprod Biol. 2021;263:261-274.
    PubMed     Abstract available


    April 2021
  9. CHOU HH, Chen WC, Yang LY, Huang HJ, et al
    Postoperative adjuvant dose-dense chemotherapy with bevacizumab and maintenance bevacizumab after neoadjuvant chemotherapy for advanced ovarian cancer: A phase II AGOG/TGOG trial.
    Eur J Obstet Gynecol Reprod Biol. 2021;262:13-20.
    PubMed     Abstract available


  10. ATHEY RA, Macdonald MC, Jha S
    Stage of ovarian cancer at diagnosis. Does presentation as an emergency make a difference?
    Eur J Obstet Gynecol Reprod Biol. 2021;261:7-11.
    PubMed     Abstract available


    March 2021
  11. ALMAHDY AM, Elassall GM, Abdelbadee AY, Abd-Elkariem AY, et al
    Prognostic value of systematic lymphadenectomy in patients with ovarian cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:179-185.
    PubMed     Abstract available


  12. GKROZOU F, Pappa C, Tsonis O, Dimitriou E, et al
    Relaxin as a potential diagnostic biomarker for ovarian cancer- A prospective study.
    Eur J Obstet Gynecol Reprod Biol. 2021;260:99-104.
    PubMed     Abstract available


    February 2021
  13. CAPMAS P, Suarthana E, Tulandi T
    Further evidence that endometriosis is related to tubal and ovarian cancers: A study of 271,444 inpatient women.
    Eur J Obstet Gynecol Reprod Biol. 2021;260:105-109.
    PubMed     Abstract available


    November 2020
  14. ZHANG JL, Li DF, Li DY, Ma LG, et al
    A rare malignant transformation of endometriosis.
    Eur J Obstet Gynecol Reprod Biol. 2020 Nov 27. pii: S0301-2115(20)30741.
    PubMed    


  15. BOURDEL N, Huchon C, Abdel Wahab C, Azais H, et al
    Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Eur J Obstet Gynecol Reprod Biol. 2020 Nov 20. pii: S0301-2115(20)30758.
    PubMed     Abstract available


  16. CARBONE MV, Cavaliere AF, Fedele C, Vidiri A, et al
    Uterine tumor resembling ovarian sex-cord tumor: Conservative surgery with successful delivery and case series.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:326-332.
    PubMed     Abstract available


  17. ZILLIOX M, Lecointre L, Azais H, Ballester M, et al
    Management of borderline ovarian tumours during pregnancy: Results of a French multi-centre study.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:412-418.
    PubMed     Abstract available


  18. VOUTSADAKIS IA
    A systematic review and meta-analysis of hormone receptor expression in low-grade serous ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:172-178.
    PubMed     Abstract available


  19. TANG X, Zhang X, Liu X, Zheng T, et al
    A novel laparoscopy-based model for the prediction of optimal cytoreduction and prognosis of epithelial ovarian cancer in a Chinese population.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:256-262.
    PubMed     Abstract available


  20. FONNES T, Telle IO, Forsse D, Falck R, et al
    Cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:25-31.
    PubMed     Abstract available


    October 2020
  21. KONSGEN D, Klinkmann G, Kaul A, Diesing K, et al
    Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:154-159.
    PubMed     Abstract available


  22. KOLEHMAINEN AM, Pasanen AM, Koivisto-Korander RL, Butzow RC, et al
    Molecular characterization in the prediction of disease extent in endometrial carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2020 Oct 16. pii: S0301-2115(20)30669.
    PubMed     Abstract available


  23. ZHAO J, Wu J, Zuo W, Kang S, et al
    A functional polymorphism in the poly(ADP-ribose) polymerase-1 gene is associated with platinum-based chemotherapeutic response and prognosis in epithelial ovarian cancer patients.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:183-189.
    PubMed     Abstract available


  24. FERRARI F, Ficarelli S, Forte S, Valenti G, et al
    Extra-abdominal ovarian cancer presenting with breast metastases at diagnosis: Case report and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:211-221.
    PubMed     Abstract available


    September 2020
  25. YOSHIHARA M, Tamauchi S, Iyoshi S, Kitami K, et al
    Does uterine preservation affect survival outcomes of patients with stage I ovarian sex cord-stromal cell tumours? A multi-institutional study.
    Eur J Obstet Gynecol Reprod Biol. 2020;254:52-56.
    PubMed     Abstract available


    August 2020
  26. CHEN S, Yang B, Fan J
    Diagnostic value of Anti-Mullerian hormone in ovarian granulosa cell tumor: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2020;253:266-272.
    PubMed     Abstract available


    July 2020
  27. KHIAT S, Provansal M, Bottin P, Saias-Magnan J, et al
    Fertility preservation after fertility-sparing surgery in women with borderline ovarian tumours.
    Eur J Obstet Gynecol Reprod Biol. 2020;253:65-70.
    PubMed     Abstract available


    June 2020
  28. PERGIALIOTIS V, Thomakos N, Frountzas M, Haidopoulos D, et al
    Perioperative blood transfusion and ovarian cancer survival rates: A meta-analysis based on univariate, multivariate and propensity score matched data.
    Eur J Obstet Gynecol Reprod Biol. 2020;252:137-143.
    PubMed     Abstract available


    April 2020
  29. DELANGLE R, Rossard L, Cirier J, Delvallee J, et al
    Isolated lymph node recurrence in epithelial ovarian cancer: Recurrence with better prognosis?
    Eur J Obstet Gynecol Reprod Biol. 2020 Apr 24. pii: S0301-2115(20)30234.
    PubMed     Abstract available


  30. HSIAO SM
    Letter to the Editor on "A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy".
    Eur J Obstet Gynecol Reprod Biol. 2020;247:257.
    PubMed    


    March 2020
  31. CHEVROT A, Hequet D, Fauconnier A, Huchon C, et al
    Impact of surgical restaging on recurrence in patients with borderline ovarian tumors: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2020;248:227-232.
    PubMed     Abstract available


    January 2020
  32. RUDAITIS V, Mikliusas V, Januska G, Jukna P, et al
    The incidence of occult ovarian neoplasia and cancer in BRCA1/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): A single-center prospective study.
    Eur J Obstet Gynecol Reprod Biol. 2020;247:26-31.
    PubMed     Abstract available


  33. NASIOUDIS D, Mastroyannis SA, Haggerty AF, Giuntoli RL 2nd, et al
    Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary.
    Eur J Obstet Gynecol Reprod Biol. 2020;248:63-70.
    PubMed     Abstract available


    December 2019
  34. LECOINTRE L, Velten M, Lodi M, Saadeh R, et al
    Impact of neoadjuvant chemotherapy cycles on survival of patients with advanced ovarian cancer: A French national multicenter study (FRANCOGYN).
    Eur J Obstet Gynecol Reprod Biol. 2019;245:64-72.
    PubMed     Abstract available


    November 2019
  35. OTIFY M, Laios A, Elshamy T, D'Angelo A, et al
    A systematic review and meta-analysis of the use of ultrasound to diagnose borderline ovarian tumours.
    Eur J Obstet Gynecol Reprod Biol. 2019;244:120-127.
    PubMed     Abstract available


  36. TARANNUM A, Sheikh H, Appiah-Sakyi K, Lindow SW, et al
    The diagnostic use of magnetic resonance imaging for acute abdominal and pelvic pain in pregnancy.
    Eur J Obstet Gynecol Reprod Biol. 2019 Nov 22. pii: S0301-2115(19)30542.
    PubMed     Abstract available


  37. RETTENMAIER MA, Micha JP, Bohart R, Goldstein BH, et al
    A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy with hyperthermic intraperitoneal chemotherapy in the treatment of advanced stage ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2019;244:101-105.
    PubMed     Abstract available


    October 2019
  38. NAMAZOV A, Gemer O, Helpman L, Hag-Yahia N, et al
    The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group study.
    Eur J Obstet Gynecol Reprod Biol. 2019;243:120-124.
    PubMed     Abstract available


  39. VAN HEERDEN J, Tjalma WA
    The multidisciplinary approach to ovarian tumours in children and adolescents.
    Eur J Obstet Gynecol Reprod Biol. 2019;243:103-110.
    PubMed     Abstract available


    September 2019
  40. BENITO V, Lubrano A, Andujar M, Mori M, et al
    Management of endometrial cancer in patients aged 80 years and older: Identifying patients who may benefit from a curative treatment.
    Eur J Obstet Gynecol Reprod Biol. 2019;242:36-42.
    PubMed     Abstract available


  41. WANG Y, Sun H, Yu A, Zhu T, et al
    Association between chemotherapy and disease-specific survival in women with borderline ovarian tumors: A SEER-based study.
    Eur J Obstet Gynecol Reprod Biol. 2019;242:92-98.
    PubMed     Abstract available


  42. NASIOUDIS D, Holcomb K
    Incidence of isolated para-aortic lymph node metastasis in early stage endometrial cancer.
    Eur J Obstet Gynecol Reprod Biol. 2019;242:43-46.
    PubMed     Abstract available


    August 2019
  43. REISER E, Aust S, Seebacher V, Reinthaller A, et al
    Gamma-glutamyltransferase as a preoperative differential diagnostic marker in patients with adnexal mass.
    Eur J Obstet Gynecol Reprod Biol. 2019;239:16-20.
    PubMed     Abstract available


    July 2019
  44. MEYDANLI MM, Aslan K, Oz M, Muftuoglu KH, et al
    A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:310-315.
    PubMed     Abstract available


  45. FALCONE F, Normanno N, Losito NS, Scognamiglio G, et al
    Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:220-225.
    PubMed     Abstract available


    May 2019
  46. NASIOUDIS D, Wilson E, Mastroyannis SA, Latif NA, et al
    Prognostic significance of elevated pre-treatment serum CA-125 levels in patients with stage I ovarian sex cord-stromal tumors.
    Eur J Obstet Gynecol Reprod Biol. 2019;238:86-89.
    PubMed     Abstract available


    March 2019
  47. LAVOUE V, Huchon C, Akladios C, Alfonsi P, et al
    Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.
    Eur J Obstet Gynecol Reprod Biol. 2019 Mar 15. pii: S0301-2115(19)30128.
    PubMed     Abstract available


  48. FISCHETTI A, Rutigliani M, Romano N, Marinaro EL, et al
    Imaging findings of ovarian leiomyosarcoma with histopathologic correlations.
    Eur J Obstet Gynecol Reprod Biol. 2019 Mar 12. pii: S0301-2115(19)30116.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: